Alcidion Group Ltd (ASX: ALC) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Alcidion Group Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $80.58 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 1.34 billion
Earnings per share -0.006
Dividend per share N/A
Year To Date Return -20.00%
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Alcidion Group Ltd (ASX: ALC)
    Latest News

    a woman
    Speculative

    4 exciting ASX small cap shares to watch in 2020

    Alcidion Group Ltd (ASX:ALC) shares are one of four at the small end of the market which I think could be…

    Read more »

    a woman
    Share Market News

    5 small-cap shares I'm watching in FY 2020

    Serko Ltd (ASX: SKO) and 4 other small-cap ASX companies worth watching in FY20.

    Read more »

    a woman
    Speculative

    10 small cap ASX shares with enormous potential

    LiveTiles Ltd (ASX:LVT) and Volpara Health Technologies Ltd (ASX:VHT) are two of ten small cap ASX shares that I think investors…

    Read more »

    a woman
    Share Market News

    5 stocks to buy under $5

    Just $5,000 could get you at least 1,000 shares in any of these companies.

    Read more »

    a woman
    Speculative

    3 exciting ASX small cap tech shares to watch in 2020

    Alcidion Group Ltd (ASX:ALC) and two other ASX small cap tech shares could be great long term investments...

    Read more »

    a woman
    Share Gainers

    Why Alcidion, Helloworld, Nearmap, & Wattle Health shares surged higher today

    The Helloworld Travel Ltd (ASX:HLO) share price and the Nearmap Ltd (ASX:NEA) share price are two of four surging notably…

    Read more »

    a woman
    Share Gainers

    Alcidion share price jumps 14% higher on Healthscope deal

    The Alcidion Group Ltd (ASX:ALC) share price has climbed higher after announcing a deal with Healthscope...

    Read more »

    a woman
    Speculative

    3 small cap ASX healthcare shares which could be destined for big things

    Volpara Health Technologies Ltd (ASX:VHT) shares are one of three that I think could have very big futures in the healthcare…

    Read more »

    a woman
    Speculative

    3 exciting small cap ASX shares to watch in 2020

    Alcidion Group Ltd (ASX:ALC) shares are one of three that small cap investors might want to watch closely in FY…

    Read more »

    a woman
    Share Gainers

    Alcidion share price rockets higher after delivering strong revenue growth in FY 2019

    The Alcidion Group Ltd (ASX:ALC) share price has rocketed higher on Thursday after delivering strong sales growth in FY 2019...

    Read more »

    a woman
    Share Market News

    Senetas share price lower as it swings to small loss

    Senetas Corporation Limited (ASX: SEN) provides cyber-security services.

    Read more »

    a woman
    Speculative

    3 small cap ASX shares that could be long-term market beaters

    Audinate Group Limited (ASX:AD8) shares are one of three that I think small cap investors ought to watch very closely...

    Read more »

    Frequently Asked Questions

    No, Alcidion does not pay dividends at this time.

    Alcidion listed on the ASX on 24 June 2011.

    ALC ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Alcidion Group Ltd

    Alcidion Group Ltd (ASX: ALC) is a provider of intelligent informatics software for the healthcare sector.

    The company builds, sells, delivers, runs, and supports solutions for healthcare providers. These include clinical, analytical, managerial, and administrative systems.

    Its products include its Miya suite, a Fast Healthcare Interoperability Resources (FHIR) system that allows comprehensive healthcare data to be exchanged between different computer systems.  Other products include Smartpage and Patientrack software.

    Alcidion derives the majority of its revenue from its Australia/New Zealand segment and also has a presence in the United Kingdom.

    ALC Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    20 Dec 2024 $0.06 $0.00 0.00% 2,350,536 $0.06 $0.06 $0.06
    19 Dec 2024 $0.06 $0.00 0.00% 648,353 $0.06 $0.06 $0.06
    18 Dec 2024 $0.06 $0.00 0.00% 2,262,046 $0.06 $0.06 $0.06
    17 Dec 2024 $0.06 $0.00 0.00% 380,705 $0.06 $0.06 $0.06
    16 Dec 2024 $0.06 $0.00 0.00% 1,309,908 $0.06 $0.06 $0.06
    13 Dec 2024 $0.06 $0.00 0.00% 2,428,047 $0.06 $0.06 $0.06
    12 Dec 2024 $0.06 $0.00 0.00% 1,516,256 $0.06 $0.06 $0.06
    11 Dec 2024 $0.06 $0.00 0.00% 394,699 $0.06 $0.06 $0.06
    10 Dec 2024 $0.06 $0.00 0.00% 131,252 $0.06 $0.06 $0.06
    09 Dec 2024 $0.06 $0.00 0.00% 642,301 $0.06 $0.06 $0.06
    06 Dec 2024 $0.06 $0.00 0.00% 347,725 $0.06 $0.06 $0.06
    05 Dec 2024 $0.06 $0.00 0.00% 172,319 $0.06 $0.06 $0.06
    04 Dec 2024 $0.06 $0.00 0.00% 1,845,830 $0.06 $0.06 $0.06
    03 Dec 2024 $0.06 $0.00 0.00% 383,905 $0.06 $0.06 $0.06
    02 Dec 2024 $0.06 $0.00 0.00% 664,282 $0.06 $0.06 $0.06
    29 Nov 2024 $0.06 $0.00 0.00% 236,994 $0.06 $0.06 $0.06
    28 Nov 2024 $0.06 $0.00 0.00% 916,836 $0.06 $0.07 $0.06
    27 Nov 2024 $0.07 $0.00 0.00% 1,003,675 $0.06 $0.07 $0.06
    26 Nov 2024 $0.07 $0.00 0.00% 1,973,768 $0.07 $0.07 $0.06
    25 Nov 2024 $0.07 $0.00 0.00% 604,670 $0.07 $0.07 $0.06
    22 Nov 2024 $0.06 $0.00 0.00% 1,235,628 $0.07 $0.07 $0.06

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    26 Apr 2024 Daniel Sharp Transfer 800,000 $44,000
    Off-market transfer. Assuming off market transfer of shares
    26 Apr 2024 Daniel Sharp Transfer 800,000 $44,000
    Off-market transfer. Assuming off market transfer of shares
    26 Apr 2024 Daniel Sharp Buy 250,000 $13,070
    On-market trade.
    23 Apr 2024 Katrina (Kate) Doyle (Quirke) Transfer 1,000,000 $46,000
    Off-market transfer. Assuming off market transfer of shares
    23 Apr 2024 Katrina (Kate) Doyle (Quirke) Transfer 1,000,000 $46,000
    Off-market transfer. Assuming off market transfer of shares
    23 Apr 2024 Katrina (Kate) Doyle (Quirke) Buy 1,000,000 $46,671
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Ms Rebecca Jayne Wilson Non-Executive DirectorNon-Executive Chairman Jul 2017
    Ms Wilson is a company director and Board advisor in Australia, UK and US and has more than 25 years of experience working within the healthcare, technology and life science sectors. She provides advice on complex stakeholder communication, issues management, investor and corporate relations, and business strategy to private and public companies, corporations, governments, and asset managers. She has mature governance and risk management experience.
    Mr William (Bill) Smart Non-Executive Director Oct 2024
    Mr Smart is a global digital health leader at both an operational and non-executive level having recently stepped down as the Global Director of External Relations, Dedalus Group, a global digital health company. Based in the United Kingdom, Will is currently Digital Non-Executive Director, Great Western Hospitals NHS Foundation Trust and was previously the CIO for Health and Social Care for England. He has held executive roles in several NHS Trusts including as Group Chief Information Officer, Royal Free London NHS Foundation Trust. In his capacity as Digital Non-Executive Director, Great Western Hospitals NHS Foundation Trust, Will is a member of the Acute Hospitals Alliance EPR Joint Committee responsible for overseeing the implementation of a new EPR across Great Western, Royal University Hospital, and Salisbury Trusts. Will is also a Director of CareTech Partners Limited providing digital advisory and consultancy support to public and private organisations and a member of the Health and Social Care Council at TechUK, a member organisation that represents and supports the UK technology sector and works with government, regulators and stakeholders.
    Ms Victoria Weekes Non-Executive Director Sep 2021
    Ms Weekes is a non-executive director with experience across a diverse range of industries built on a successful executive career in investment markets and financial services. Victorias 30 years of experience in the finance and banking sector includes Csuite roles as a Managing Director at Citigroup and Executive General Manager at Westpac. As the immediate past Chair of the Sydney Local Health District, Victoria has a deep understanding of the healthcare sector where she served as Chair of its Education & Research Committee and Deputy Chair. She is the chairman of risk committee.
    Ms Katrina (Kate) Elizabeth Doyle (Quirke) Chief Executive OfficerExecutive DirectorManaging Director Jul 2018
    Ms Doyle has been CEO of Alcidion since 2018, prior to which she was CEO of MKM Health until it was acquired by Alcidion. She has been involved in large systems procurements and implementations of healthcare information technology across Australia, United Kingdom, New Zealand and Southeast Asia. Her background involves holding leading management roles at some of the largest healthcare software firms where she has had an impact on strategic product direction across
    the health sector and believes astute application of information technology will support the transformation of healthcare delivery worldwide.
    Mr Daniel Sharp Non-Executive Director Sep 2021
    Mr Sharp has over 25 years senior executive experience in investment banking and corporate finance. From 2012-2020, Daniel was an Executive Director of Corporate Finance at Canaccord Genuity where he led dozens of equity capital market transactions and corporate finance advisory projects across the healthcare, life sciences, technologies, financial services and general industrials sectors. Prior to his executive role at Canaccord, Daniel headed the corporate finance division at two of Australia's independent Investment Banking/Stockbroking firms. He is closely connected to strong networks of institutional, family office and high net worth investors both in Australia and overseas. He is also a member of risk committee.
    Mr Michael Sapountzis Company Secretary Mar 2019
    -
    Matthew Gepp Chief Financial Officer
    -
    Michael Sapountzis Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    J P Morgan Nominees Australia Pty Limited 156,589,750 11.66%
    Mr Malcolm Pradhan 134,582,403 10.02%
    Bond Street Custodians Limited <Salter D79836 A/C> 73,000,000 5.44%
    Mr Raymond Howard Blight 68,801,020 5.12%
    Rewmicman Pty Ltd <Smallman Family A/C> 28,810,441 2.15%
    Mrs Katrina Elizabeth Doyle 27,793,199 2.07%
    Caledonia Nominees Pty Ltd <Caledonia A/C> 19,976,377 1.49%
    MNMD Pty Ltd <Quirke Super Fund A/C> 19,668,086 1.47%
    BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> 17,189,236 1.28%
    Bond Street Custodians Limited <RSALTE - D62375 A/C> 13,999,000 1.04%
    Mr Dean Anthony Mackenzie 13,143,801 0.98%
    Mr Paul John Van Dyk 12,300,000 0.92%
    Sandhurst Trustees Ltd <Cyan C3G Fund A/C> 10,469,114 0.78%
    Citicorp Nominees Pty Limited 10,272,574 0.77%
    Rangiora London Pty Limited <Rangiora-London A/C> 7,800,000 0.58%
    Emerald Shares Pty Limited <Emerald Unit A/C> 7,100,000 0.53%
    Mr Vivek Ramakrishnan and Miss Nisha Srinivasan 7,021,913 0.52%
    Finclear Services Pty Ltd <Superhero Securities A/C> 6,807,539 0.51%
    Hudson Retirement Pty Ltd <Seagulls Super A/C> 6,524,244 0.49%
    Webzone Holdings Pty Ltd 5,820,000 0.42%

    Profile

    since

    Note